Bristol-Myers Squibb Company (BMY) · page 56 of 197
Uses a 'patent cliff' metaphor to argue against the acquisition.
Activist deck · preempt_rebuttal · preempt_rebuttal · dense density
Slide locked Sign in to view
Slide schematic 7/9
callout 1/1 chart 1/1 metric 0/1 quote 1/2 source-note 1/1 subtitle 1/1 title 2/2
2 without position metric 1 · quote 1
metric · primaryquote
Components 9
primary line primary pull-quote quote source-note subtitle action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1